Panagora Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Panagora Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$804K	Buy	+81,089	New	+$678K	﹤0.01%	783

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Panagora Asset Management's DNA Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 81,089 shares worth $804K. The stake represents ﹤0.01% of the portfolio and ranks #783 among its holdings.

67 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Panagora Asset Management held 81,089 shares of Ginkgo Bioworks worth $804K as of Q2 2026.
Ginkgo Bioworks was a new Panagora Asset Management position in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #783 holding.
67 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.